AJP - Heart and Circulatory Physiology, Vol 270, Issue 5 1640-H1648, Copyright © 1996 by American Physiological Society

ARTICLES

Effects of nitric oxide/EDRF on platelet surface glycoproteins

A. D. Michelson, S. E. Benoit, M. I. Furman, W. L. Breckwoldt, M. J. Rohrer, M. R. Barnard and J. Loscalzo
Department of Pediatrics, University of Massachusetts Medical School, Worcester 01655, USA.

We examined the effects of nitric oxide (NO)/endothelium-derived relaxing factor (EDRF) on platelet surface glycoproteins (GP). As determined by flow cytometry, in both a washed platelet system and platelet-rich plasma, the EDRF congener (S-nitroso-N-acetylcysteine) markedly inhibited both the thrombin-induced and the (stable thromboxane A2 analogue) U-46619-induced upregulation of P-selectin (alpha-granule protein), CD63 (lysosomal protein), and the GPIIb-IIIa complex (fibrinogen receptor) but minimally inhibited downregulation of the GPIb-IX complex (von Willebrand factor receptor). The inhibitory effects of EDRF were markedly reduced in whole blood or by the addition of washed erythrocytes. Platelets in whole blood were still responsive to guanosine 3',5'-cyclic monophosphate (cGMP), as shown by complete inhibition of P-selectin upregulation by the stable analogue N6,2'-O dibutyryl cGMP. These data suggests that 1) cGMP negatively regulates the platelet surface expression of P-selectin, CD63, and the GPIIb-IIIa complex but not the platelet surface expression of the GPIb-IX complex and 2) hemoglobin within erythrocytes inhibits the effects of EDRF/NO on platelet surface glycoproteins.

This article has been cited by other articles:

				R. F. Machado, A. Anthi, M. H. Steinberg, D. Bonds, V. Sachdev, G. J. Kato, A. M. Taveira-DaSilva, S. K. Ballas, W. Blackwelder, X. Xu, et al. N-terminal pro-brain natriuretic peptide levels and risk of death in sickle cell disease. JAMA, July 19, 2006; 296(3): 310 - 318. [Abstract] [Full Text] [PDF]

				Y. Yang and J. Loscalzo Regulation of Tissue Factor Expression in Human Microvascular Endothelial Cells by Nitric Oxide Circulation, May 9, 2000; 101(18): 2144 - 2148. [Abstract] [Full Text] [PDF]

				J. E. Freedman, R. Sauter, E. M. Battinelli, K. Ault, C. Knowles, P. L. Huang, and J. Loscalzo Deficient Platelet-Derived Nitric Oxide and Enhanced Hemostasis in Mice Lacking the NOSIII Gene Circ. Res., June 25, 1999; 84(12): 1416 - 1421. [Abstract] [Full Text] [PDF]

				S. Massberg, M. Sausbier, P. Klatt, M. Bauer, A. Pfeifer, W. Siess, R. Fassler, P. Ruth, F. Krombach, and F. Hofmann Increased Adhesion and Aggregation of Platelets Lacking Cyclic Guanosine 3',5'-Monophosphate Kinase I J. Exp. Med., April 19, 1999; 189(8): 1255 - 1264. [Abstract] [Full Text] [PDF]

				H. Christou, B. Magnani, D. S. Morse, E. N. Allred, L. J. Van Marter, D. L. Wessel, and S. Kourembanas Inhaled Nitric Oxide Does Not Affect Adenosine 5'-Diphosphate-dependent Platelet Activation in Infants With Persistent Pulmonary Hypertension of the Newborn Pediatrics, December 1, 1998; 102(6): 1390 - 1393. [Abstract] [Full Text] [PDF]

				A. Gries, C. Bode, K. Peter, A. Herr, H. Bohrer, J. Motsch, and E. Martin Inhaled Nitric Oxide Inhibits Human Platelet Aggregation, P-Selectin Expression, and Fibrinogen Binding In Vitro and In Vivo Circulation, April 21, 1998; 97(15): 1481 - 1487. [Abstract] [Full Text] [PDF]

				M. I. Furman, L. Liu, S. E. Benoit, R. C. Becker, M. R. Barnard, and A. D. Michelson The cleaved peptide of the thrombin receptor is a strong platelet agonist PNAS, March 17, 1998; 95(6): 3082 - 3087. [Abstract] [Full Text] [PDF]

				P. Provost, J. Tremblay, and Y. Merhi The Antiadhesive and Antithrombotic Effects of the Nitric Oxide Donor SIN-1 Are Combined With a Decreased Vasoconstriction in a Porcine Model of Balloon Angioplasty Arterioscler. Thromb. Vasc. Biol., September 1, 1997; 17(9): 1806 - 1812. [Abstract] [Full Text]